Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1998
11/26/1998CA2291477A1 Human semaphorin e and polynucleotides encoding it
11/26/1998CA2291156A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
11/26/1998CA2290825A1 Short peptides which selectively modulate intracellular signalling
11/26/1998CA2290783A1 Modulators of tissue regeneration
11/26/1998CA2290778A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
11/26/1998CA2290774A1 Mycobacterium tuberculosis antigens for immunotherapy and diagnosis of tuberculosis
11/26/1998CA2290769A1 Ubiquitin conjugation proteins
11/26/1998CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998CA2290705A1 Alkylated hexapeptides
11/26/1998CA2290657A1 A method to increase the survival of transplanted cells
11/26/1998CA2290602A1 88kda tumorigenic growth factor and antagonists
11/26/1998CA2290556A1 Method for assisting in differential diagnosis and treatment of autistic syndromes
11/26/1998CA2290459A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
11/26/1998CA2290426A1 Glial cell line-derived neurotrophic factor receptors
11/26/1998CA2290388A1 Urea and thiourea derivatives of glycopeptides
11/26/1998CA2290040A1 Smad7 and uses thereof
11/26/1998CA2289945A1 Human uncoupling protein 3
11/26/1998CA2289918A1 Mammalian cell transduction for use in gene therapy
11/26/1998CA2289917A1 Dna encoding canine interleukin-1 receptor antagonist
11/26/1998CA2289906A1 Smad2 phosphorylation and interaction with smad4
11/26/1998CA2288964A1 Novel administration of thrombopoietin
11/26/1998CA2288622A1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
11/26/1998CA2261681A1 Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions
11/25/1998EP0879889A2 A novel member of the IL-1 family, IL-1 delta
11/25/1998EP0879888A2 Patched-2 polypeptides and polynucleotides and methods for their production
11/25/1998EP0879887A1 A human gene similar to a secreted murine protein SDF5 (ATG-1622)
11/25/1998EP0879885A1 A novel human gene similar to a secreted murine protein sFRP-1
11/25/1998EP0879883A1 ATG-1120 (AIF-1-DELTA), a splice variant of AIF-1/RC-9
11/25/1998EP0879882A1 ATG-1100 (AIF-1-Gamma), a splice variant of AIF-1/RC-9
11/25/1998EP0879881A1 A human gene similar to a secreted protein frizb (ATG-1639)
11/25/1998EP0879880A1 ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9
11/25/1998EP0879879A2 Polypeptide deformylase 1 (Def1)
11/25/1998EP0879825A2 Derivatives of antibibioc A82846B(Chloroorienticin A)
11/25/1998EP0879604A1 Konjugate comprising a Folic acid antagonist and a carrier
11/25/1998EP0879602A1 A method to increase the survival of transplanted cells
11/25/1998EP0879294A1 Transduced human hematopoietic stem cells
11/25/1998EP0879291A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system
11/25/1998EP0879289A1 Human dnase resistant to actin inhibition
11/25/1998EP0879288A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy
11/25/1998EP0879286A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
11/25/1998EP0879285A1 Fas ligand fusion protein
11/25/1998EP0879281A2 Methods and compositions for transforming dendritic cells and activating t cells
11/25/1998EP0879279A1 Diabetes therapy
11/25/1998EP0879245A1 Synthetic il-10 analogues
11/25/1998EP0879241A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor
11/25/1998EP0879062A2 Nucleic acid delivery vehicle
11/25/1998EP0879061A2 Spermatogenesis control
11/25/1998EP0879059A1 Methods for retreatment of patients afflicted with hepatitis c using consensus interferon
11/25/1998EP0879056A1 MODULATION OF TH1/TH2 CYTOKINE EXPRESSION BY RIBAVIRIN$m(3) AND RIBAVIRIN$m(3) ANALOGS IN ACTIVATED T-LYMPHOCYTES
11/25/1998EP0879035A1 Bismuth-containing compounds in topical dosage forms
11/25/1998EP0833636A4 Method for inhibiting neoplastic disease in mammals
11/25/1998EP0720624B1 Retargeting antibodies
11/25/1998EP0697887B1 Stable liquid compositions of gamma interferon
11/25/1998EP0696920B1 Improved pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
11/25/1998EP0695189B1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors
11/25/1998EP0669835B1 Dietary hypocholesterolaemic compositions comprising soya proteins and sitosterols
11/25/1998EP0663916B1 O-alkylated rapamycin derivative and its use, particularly as immunosuppressant
11/25/1998EP0639202B1 Stable polypeptide composition
11/25/1998EP0633789B1 Wound dressing, wound plaster or carrier matrix
11/25/1998EP0601043B1 Hybrid cytokines
11/25/1998EP0553113B1 Adhesion receptors for pathogenic or opportunistic microorganisms
11/25/1998EP0486562B1 Mutant pseudorabies virus, and vaccines containing the same
11/25/1998CN1200148A Methods for enhancing the production of viral vaccines in cell culture by interferon suppression
11/25/1998CN1200147A Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/25/1998CN1200127A Novel opioid peptides
11/25/1998CN1200122A Lubeluzole N-oxide
11/25/1998CN1200037A Chicken interleukin-15 and uses thereof
11/25/1998CN1200032A Process to manufacture implants containing bioactive peptides
11/25/1998CN1199738A Ribosome deactivating protein originating from octagon towel gourd
11/25/1998CN1199642A LHRH-antagonists in treatment of fertility disorders
11/24/1998US5840918 Isoprenyl transferase inhibitors
11/24/1998US5840896 Method of preventing or limiting reperfusion damage
11/24/1998US5840875 Treating diseases involving the mammalian kidney proximal tubule epithelium
11/24/1998US5840874 Hammerhand ribozymes
11/24/1998US5840871 Pure polynucleotide sequence as hybridization probes complementary to the polynucleotide; transformed cell cultures yield protein; possible anticancer agents for breast and cell cancer
11/24/1998US5840869 DNA encoding interleukin-4 receptors
11/24/1998US5840857 Purification of post-menopausal urinary concentrate by immunochromatography and reverse phase high pressure liquid chromatography; biologically active product is free from lutenizing hormone and other proteins; fertility agents
11/24/1998US5840856 Antibodies to a human PF4 superfamily receptor
11/24/1998US5840854 Monoclonal antibody BR110 and uses thereof
11/24/1998US5840853 Parathyroid hormone receptor and DNA encoding same
11/24/1998US5840852 Method for producing ultrapure stable polmerized hemoglobin blood-substitute
11/24/1998US5840851 Contacting hemoglobin-containing lysate with immobilized metal affinity chromatography resin charged with divalent metal ion
11/24/1998US5840848 Facilitating removal of perichondrial membrane from vertebrate cartilage tissue using acidic solution containing acid protease
11/24/1998US5840847 Purified prostaglandin receptor FP
11/24/1998US5840846 Fibronectin binding protein as well as its preparation
11/24/1998US5840845 Senescent cell derived inhibitors of DNA synthesis
11/24/1998US5840844 Soluble lymphocyte homing receptors
11/24/1998US5840843 Synthetic polypeptides as inhibitors of HIV-1
11/24/1998US5840842 Receptor-type phosphotyrosine phosphatase-sigma
11/24/1998US5840839 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
11/24/1998US5840837 Coupling protected amino acids, optionally on a resin, deprotecting and purifying polypeptide product
11/24/1998US5840836 Bind with antiboides found in sera of patients afflicted with insulin-dependent (type i) diabetes mellitus; polypeptides or fragments thereof used in diagnosis of diabetes, and in detecting or blocking human immunoglobulin, t-cells, or
11/24/1998US5840835 Inhibitors of peptide binding to MHC class II proteins
11/24/1998US5840832 Transcription factor regulating MHC expression, CDNA and genomic clones encoding same and retroviral expression constructs thereof
11/24/1998US5840771 Prophylaxis against diseases tramsmittable by sexual contact, and therapy of such diseases
11/24/1998US5840770 Immunoenhancement or immune-potentiation therapy comprising administration of potassium, insulin, glucose and optionally, thyroid, a cholinergic agent and bicarbonate
11/24/1998US5840759 Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
11/24/1998US5840757 Lipid emulsion intended for parenteral or enteral feeding
11/24/1998US5840736 Methods and compositions for stimulating neurite growth
11/24/1998US5840733 Argatroban derivatives which can be covalently linked to various blood components